After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Additional Phase 1 Data for FT819 Off-the-Shelf CAR T-cell Product Candidate in Moderate-to-Severe Systemic Lupus ...

Financially, Creative Medical has limited cash reserves, high cash burn, and will likely need dilutive financing. Click here ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has secured $20 million in financing. Trailhead specializes in precisely differentiating induced pluripotent stem ...

Inhibition of PRC2 enables self-renewal of blastoid-competent naive pluripotent stem cells from chimpanzee. Cell Stem Cell , 2025; 32 (4): 627 DOI: 10.1016/j.stem.2025.02.002 Cite This Page : ...

Our ultimate goal is to enhance the prevalence of regenerative medicine by establishing iPS cell banking services for individuals and making iPS cells accessible to other development companies working ...

Press release photo Bangladesh Medical University pro-vice-chancellor, research and development, Professor Md Mujibur Rahman Hawlader on Tuesday said that a stem cell bank would be launched at the ...

A Phase I/II trial by Japan’s Kyoto University Hospital and the Center for iPS Cell Research and Application (CiRA) researcher and clinician team has demonstrated encouraging outcomes with the use of ...

The cells, known as human-induced pluripotent stem cells, are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are found in early ...